PFunding Rounds · Post-IPO
Pangaea Oncology — Post-IPO · €2.5M
Pangaea issued 1.25M new shares at €2.00 each (€2.5M), and they began trading on the MAB on 22 August 2018. This was part of a €5M capital increase announced in June 2018, half of which the Solans family (Pikolin owners, about 36% holders) had committed to take through a participative loan from Hersol XXL. Sources do not name who subscribed the shares issued.
Lead unknown
RoundPost-IPO
Announced20 Aug 2018Not counted in totals
CityBarcelona
SectorHealthtech / Precision oncologySource
P
P
The company
Investors
No investors were disclosed for this round.